Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Expression and prognostic role of SKIP in human breast carcinoma.

Liu X, Ni Q, Xu J, Sheng C, Wang Q, Chen J, Yang S, Wang H.

J Mol Histol. 2014 Apr;45(2):169-80. doi: 10.1007/s10735-013-9546-z. Epub 2013 Oct 23.

PMID:
24150787
2.

Expression and prognostic role of SGTA in human breast carcinoma correlates with tumor cell proliferation.

Zhu T, Ji Z, Xu C, Peng Z, Gu L, Zhang R, Liu Y.

J Mol Histol. 2014 Dec;45(6):665-77. doi: 10.1007/s10735-014-9586-z. Epub 2014 Jul 16.

PMID:
25027991
3.

High SKIP expression is correlated with poor prognosis and cell proliferation of hepatocellular carcinoma.

Liu G, Huang X, Cui X, Zhang J, Wei L, Ni R, Lu C.

Med Oncol. 2013;30(3):537. doi: 10.1007/s12032-013-0537-4. Epub 2013 May 22.

PMID:
23696020
4.

High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.

Liu X, Yao N, Qian J, Huang H.

Med Oncol. 2014 Mar;31(3):878. doi: 10.1007/s12032-014-0878-7. Epub 2014 Feb 13.

PMID:
24522810
5.

Clinicopathological implications of Tiam1 overexpression in invasive ductal carcinoma of the breast.

Li Z, Liu Q, Piao J, Hua F, Wang J, Jin G, Lin Z, Zhang Y.

BMC Cancer. 2016 Aug 25;16(1):681. doi: 10.1186/s12885-016-2724-0.

6.

Expression of XB130 in human ductal breast cancer.

Li J, Sun W, Wei H, Wang X, Li H, Yi Z.

Int J Clin Exp Pathol. 2015 May 1;8(5):5300-8. eCollection 2015.

7.

Cytoplasmic Skp2 expression is associated with p-Akt1 and predicts poor prognosis in human breast carcinomas.

Liu J, Wei XL, Huang WH, Chen CF, Bai JW, Zhang GJ.

PLoS One. 2012;7(12):e52675. doi: 10.1371/journal.pone.0052675. Epub 2012 Dec 27. Erratum in: PLoS One. 2013;8(7). doi:10.1371/annotation/d8502df1-611d-4d4a-b697-acaee15ac8c8.

8.

Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.

Yuan SS, Hou MF, Hsieh YC, Huang CY, Lee YC, Chen YJ, Lo S.

J Natl Cancer Inst. 2012 Oct 3;104(19):1485-502. doi: 10.1093/jnci/djs355. Epub 2012 Aug 22.

PMID:
22914783
9.

The RNA-binding protein Sam68 regulates tumor cell viability and hepatic carcinogenesis by inhibiting the transcriptional activity of FOXOs.

Zhang T, Wan C, Shi W, Xu J, Fan H, Zhang S, Lin Z, Ni R, Zhang X.

J Mol Histol. 2015 Dec;46(6):485-97. doi: 10.1007/s10735-015-9639-y. Epub 2015 Oct 5.

PMID:
26438629
10.

Clinicopathological significance of ARID1B in breast invasive ductal carcinoma.

Shao F, Guo T, Chua PJ, Tang L, Thike AA, Tan PH, Bay BH, Baeg GH.

Histopathology. 2015 Nov;67(5):709-18. doi: 10.1111/his.12701. Epub 2015 May 17.

PMID:
25817822
11.

Validity of the proliferation markers Ki67, TOP2A, and RacGAP1 in molecular subgroups of breast cancer.

Milde-Langosch K, Karn T, Müller V, Witzel I, Rody A, Schmidt M, Wirtz RM.

Breast Cancer Res Treat. 2013 Jan;137(1):57-67. doi: 10.1007/s10549-012-2296-x. Epub 2012 Nov 8.

PMID:
23135572
12.

High levels of γ-glutamyl hydrolase (GGH) are associated with poor prognosis and unfavorable clinical outcomes in invasive breast cancer.

Shubbar E, Helou K, Kovács A, Nemes S, Hajizadeh S, Enerbäck C, Einbeigi Z.

BMC Cancer. 2013 Feb 1;13:47. doi: 10.1186/1471-2407-13-47.

13.

LETM1 overexpression is correlated with the clinical features and survival outcome of breast cancer.

Li N, Zheng Y, Xuan C, Lin Z, Piao L, Liu S.

Int J Clin Exp Pathol. 2015 Oct 1;8(10):12893-900. eCollection 2015.

14.

Prognostic value of proliferation assay in the luminal, HER2-positive, and triple-negative biologic classes of breast cancer.

Aleskandarany MA, Green AR, Benhasouna AA, Barros FF, Neal K, Reis-Filho JS, Ellis IO, Rakha EA.

Breast Cancer Res. 2012 Jan 6;14(1):R3.

15.

SKIP expression is correlated with clinical prognosis in patients with bladder cancer.

Wang L, Zhang M, Wu Y, Cheng C, Huang Y, Shi Z, Huang H.

Int J Clin Exp Pathol. 2014 Mar 15;7(4):1695-701. eCollection 2014.

16.

Decreased expression and prognostic role of EHD2 in human breast carcinoma: correlation with E-cadherin.

Shi Y, Liu X, Sun Y, Wu D, Qiu A, Cheng H, Wu C, Wang X.

J Mol Histol. 2015 Apr;46(2):221-31. doi: 10.1007/s10735-015-9614-7. Epub 2015 Mar 12.

PMID:
25758127
17.

Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.

Hein S, Müller V, Köhler N, Wikman H, Krenkel S, Streichert T, Schweizer M, Riethdorf S, Assmann V, Ihnen M, Beck K, Issa R, Jänicke F, Pantel K, Milde-Langosch K.

Breast Cancer Res Treat. 2011 Sep;129(2):347-60. doi: 10.1007/s10549-010-1219-y. Epub 2010 Oct 23.

PMID:
20972617
18.

Low expression of ULK1 is associated with operable breast cancer progression and is an adverse prognostic marker of survival for patients.

Tang J, Deng R, Luo RZ, Shen GP, Cai MY, Du ZM, Jiang S, Yang MT, Fu JH, Zhu XF.

Breast Cancer Res Treat. 2012 Jul;134(2):549-60. doi: 10.1007/s10549-012-2080-y. Epub 2012 May 15. Erratum in: Breast Cancer Res Treat. 2016 Apr;156(2):403-4.

PMID:
22585231
19.

Clinical implications of high NQO1 expression in breast cancers.

Yang Y, Zhang Y, Wu Q, Cui X, Lin Z, Liu S, Chen L.

J Exp Clin Cancer Res. 2014 Feb 5;33:14. doi: 10.1186/1756-9966-33-14.

20.

Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.

Wang H, Liu XB, Chen JH, Wang QQ, Chen JP, Xu JF, Sheng CY, Ni QC.

Exp Mol Pathol. 2014 Oct;97(2):191-201. doi: 10.1016/j.yexmp.2014.07.012. Epub 2014 Jul 16.

PMID:
25036402

Supplemental Content

Support Center